Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent ...

Retrieved on: 2021-07-27 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Amgen To Acquire Privately Held Teneobio For $900 Million In Cash With Future Contingent .... View article details on hiswai:

Excerpt

A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions ...

Article found on: markets.businessinsider.com